|
Volumn 88, Issue 12, 2001, Pages 1639-1643
|
Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
TAMOXIFEN;
ADULT;
AGED;
ARTICLE;
AXILLARY LYMPH NODE;
BONE METASTASIS;
BRAIN METASTASIS;
BREAST CARCINOMA;
CANCER DIAGNOSIS;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURGERY;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
FEMALE;
FOLLOW UP;
FUNCTIONAL DISEASE;
HUMAN;
HUMAN TISSUE;
LUNG METASTASIS;
LYMPH NODE DISSECTION;
LYMPH NODE METASTASIS;
LYMPHEDEMA;
MAJOR CLINICAL STUDY;
MALE;
MORBIDITY;
PHYSICAL DISABILITY;
PHYSIOTHERAPY;
PRIORITY JOURNAL;
QUESTIONNAIRE;
SENTINEL LYMPH NODE BIOPSY;
ADULT;
AGED;
AGED, 80 AND OVER;
AXILLA;
BREAST NEOPLASMS;
CARCINOMA, DUCTAL, BREAST;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
LYMPHATIC METASTASIS;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEOPLASM RECURRENCE, LOCAL;
POSTOPERATIVE CARE;
PROSPECTIVE STUDIES;
SENTINEL LYMPH NODE BIOPSY;
TREATMENT OUTCOME;
|
EID: 0035205445
PISSN: 00071323
EISSN: None
Source Type: Journal
DOI: 10.1046/j.0007-1323.2001.01935.x Document Type: Article |
Times cited : (129)
|
References (17)
|